Tentarix Biotherapeutics, Inc
10355 Science Center Drive
Suite 120
San Diego
CA
92121
United States
Website: https://www.tentarix.com/home
Email: info@tentarix.com
About Tentarix Biotherapeutics, Inc
Utilizing nature's diversity engine, Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology. On an unprecedented scale, we are leading a fundamental change in the methods of discovery and engineering of multi-specific biologics.
4 articles about Tentarix Biotherapeutics, Inc
-
Tentarix Biotherapeutics Completes Series B Financing Bringing Total Equity and Upfront Deal Consideration to $132 Million
9/6/2023
Tentarix Biotherapeutics, a biotechnology company focused on leveraging its proprietary Tentacles™ platform to discover and develop multi-functional, conditional protein therapeutics, today announced it has raised $35 million in a Series B financing led by Amplitude Ventures with participation from Gilead Sciences, Inc., and founding investors Versant Ventures and Samsara BioCapital.
-
Gilead and Tentarix to Discover and Develop Novel Therapies to Address Unmet Medical Needs Across Cancer and Inflammation
8/15/2023
Gilead Sciences, Inc. and Tentarix Biotherapeutics announced that the companies established three multi-year collaborations leveraging Tentarix’s proprietary Tentacles™ platform to discover and develop multi-functional, conditional protein therapeutics for oncology and inflammatory diseases.
-
Tentarix Biotherapeutics Announces the Strengthening of its Leadership and Advisory Teams
5/20/2022
Tentarix Biotherapeutics LP, a biotechnology company developing first-in-class targeted, conditional antibody-based multifunctional biotherapies, today announced the formation of a Scientific Advisory Board (SAB) and appointments to its Board of Directors and leadership team.
-
Money on the Move: October 13 – 19
10/20/2021
Investors can take their pick of life sciences companies, with more innovative ideas and treatments being added to pipelines daily. Here's who brought in the sheaves this week.